Literature DB >> 27408401

Dysfibrinogenemia with Subgaleal Hematoma: An Unusual Presentation.

Manika Khare1, Vijay Kumar1, Sadhna Marwah1, A S Nigam1, Gurdeep Buxi1.   

Abstract

Entities:  

Year:  2015        PMID: 27408401      PMCID: PMC4925534          DOI: 10.1007/s12288-015-0606-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  13 in total

1.  Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.

Authors:  H R Gralnick; H Givelber; E Abrams
Journal:  N Engl J Med       Date:  1978-08-03       Impact factor: 91.245

Review 2.  Laboratory diagnosis of dysfibrinogenemia.

Authors:  Mark T Cunningham; John T Brandt; Michael Laposata; John D Olson
Journal:  Arch Pathol Lab Med       Date:  2002-04       Impact factor: 5.534

Review 3.  The molecular basis of quantitative fibrinogen disorders.

Authors:  R Asselta; S Duga; M L Tenchini
Journal:  J Thromb Haemost       Date:  2006-10       Impact factor: 5.824

4.  Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.

Authors:  M J O'Kane; G B Wisdom; Z R Desai; G P Archbold
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Dysfibrinogenemia in obstructive liver disease.

Authors:  J Levy; M J Pettei; J I Weitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Nov-Dec       Impact factor: 2.839

6.  Acquired dysfibrinogenaemia in liver disease.

Authors:  J L Francis; D J Armstrong
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

7.  Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.

Authors:  A Dear; S O Brennan; M J Sheat; J M Faed; P M George
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

Review 8.  Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.

Authors:  F Haverkate; M Samama
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249

9.  Acquired dysfibrinogenemia secondary to mithramycin toxicity.

Authors:  M A Ashby; J Lazarchick
Journal:  Am J Med Sci       Date:  1986-07       Impact factor: 2.378

Review 10.  Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.

Authors:  A Casini; M Neerman-Arbez; R A Ariëns; P de Moerloose
Journal:  J Thromb Haemost       Date:  2015-05-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.